Table 3.
n (%) | HR | 95% CI | P-value | |
---|---|---|---|---|
Overall Survival (Univariate analysis) | ||||
Age | 346/346 (100) | 2.30 | 1. 44-4.58 | 0.0083 |
Ca125 | 296/346 (86) | 0.87 | 0.37-1.82 | 0.5562 |
Stage | 346/346 (100) | 2.99 | 1.38-7.84 | 0.0038 |
HIF1A | 341/346 (99) | 1.03 | 0.79-1.34 | 0.781 |
GBP1 | 329/346 (95) | 0.88 | 0.67-1.15 | 0.3568 |
TUBB3 | 318/346 (92) | 1.67 | 1.26-2.21 | 0.0004 |
NEK6 | 277/346 (80) | 1.37 | 1.01-1.82 | 0.0366 |
Score | 271/346 (78) | 2.28 | 1.29-4.09 | 0.006 |
Overall Survival (Multivariate analysis) | ||||
Age | 346/346 (100) | 2.27 | 1.16-4.52 | 0.0167 |
Stage | 346/346 (100) | 2.87 | 1.32-7.52 | 0.0121 |
TUBB3 | 318/346 (92) | 1.71 | 1.29-2.27 | 0.0003 |
NEK6 | 277/346 (80) | 1.45 | 1.08-1.94 | 0.013 |
Score | 271/346 (78) | 2.29 | 1.27-4.10 | 0.006 |